The Syphilis Immunoassay Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of Syphilis Immunoassay Diagnostics has experienced significant growth recently. In 2024, the market was valued at $31.25 billion and it is anticipated to increase to $33.76 billion in 2025. This projected growth represents a Compound Annual Growth Rate (CAGR) of 8.0%.
The market size for syphilis immunoassay diagnostics is projected to reach $45.42 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 Syphilis Immunoassay Diagnostics Market Report and Uncover Key Trends Now!The drivers in the syphilis immunoassay diagnostics market are:
• Rise in socioeconomic factors such as STDs
• Increasing percentage of unidentified sex
• Growing incidences of fatal syphilis diseases
• Growing initiatives by the government and rising emphasis on early detection of the diseases
The syphilis immunoassay diagnostics market covered in this report is segmented –
1) By Product: Analyzers, Reagents, Kits, Other Products
2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Application: Men, Women
4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users
The trends in the syphilis immunoassay diagnostics market are:
• The adoption of innovative technologies is a significant emerging trend in the market.
• Development of rapid point-of-care tests is becoming an influential trend.
• There is growing demand for home test kits in the syphilis immunoassay diagnostics market.
• Advancements in laboratory testing methods and expansion of diagnostic laboratory techniques are shaping the market's future.
The major players in the syphilis immunoassay diagnostics market are:
• F.Hoffmann-La Roche Ltd
North America was the largest region in the syphilis immunoassay diagnostics market in 2024